IL6 and cholangiocarcinoma: IL-6 stimulation enhanced SLPI expression and promoted tumorigenic phenotypes in both non-tumorigenic cholangiocytes (MMNK-1) and CCA cells (KKU-213A and KKU-213AL5), with a more pronounced effect observed in MMNK-1 cells.